Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000424671

Medchemexpress LLC NN1177 (TFA) | 98.7% | 4570.07 (free base) | 5 MG
SDP

Catalog No. 5000424671
Encompass_Preferred

NN1177 TFA (NNC9204-1177 TFA) is a long-acting GLP-1/glucagon receptor co-agonist. This compound is known to induce dose-dependent body weight loss in diet-induced obese mice and improves glucose tolerance. It has also been shown to reduce liver fat and relevant inflammatory and fibrosis biomarkers in NASH models.

  • Long-acting GLP-1/glucagon receptor co-agonist
  • Induces body weight loss
  • Improves glucose tolerance
  • Reduces liver fat
  • Reduces inflammatory and fibrosis relevant biomarkers
  • For research use only

Catalog No. 50-004-24671 Supplier Medchemexpress LLC Supplier No. HYP10032A5MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

NN1177 TFA (NNC9204-1177 TFA) is a long-acting GLP-1/glucagon receptor co-agonist. This compound is known to induce dose-dependent body weight loss in diet-induced obese mice and improves glucose tolerance. It has also been shown to reduce liver fat and relevant inflammatory and fibrosis biomarkers in NASH models.

  • Long-acting GLP-1/glucagon receptor co-agonist
  • Induces body weight loss
  • Improves glucose tolerance
  • Reduces liver fat
  • Reduces inflammatory and fibrosis relevant biomarkers
  • For research use only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.